ArticleAnatomy & cell biology2025
Elevated osteopontin reflects systemic inflammation in experimental autoimmune encephalomyelitis.
Article in Anatomy & cell biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We examined the expression and localization of osteopontin (OPN) in various organs in mice with experimental autoimmune encephalomyelitis (EAE). To evaluate the level of OPN in blood and various tissues, enzyme-linked immunosorbent assay and western blot analysis of OPN were performed. The serum level of OPN was significantly increased in mice with EAE, and OPN was upregulated in all tissues examined, including the liver, kidneys, intestines, and spinal cord. OPN immunoreactivity was noted in inflammatory cells (mainly macrophages) and was enhanced in constitutively expressed cell types in the examined organs. In sum, OPN, a pro-inflammatory and immunomodulatory mediator, was elevated in all tissues following EAE induction, resulting in increased blood concentrations. These findings suggest that OPN may function as a key extracellular matrix component contributing to systemic disorders in autoimmune disease models.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.